More than 10% of the general U.S. adult population have CRS symptoms. Most report severe symptoms, lack of satisfaction with current treatment options, and a substantial adverse impact on daily functioning.
No takes yet. Share an insight, caveat, or question.
Palmer et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: